| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 31 | 2023 | 1871 | 2.980 |
Why?
|
| Prostatic Neoplasms | 56 | 2024 | 11039 | 2.880 |
Why?
|
| Laparoscopy | 19 | 2024 | 2121 | 2.620 |
Why?
|
| Prostate | 20 | 2024 | 1764 | 2.370 |
Why?
|
| Intermediate Filament Proteins | 59 | 1994 | 269 | 2.220 |
Why?
|
| Ultrasonography, Interventional | 5 | 2021 | 1483 | 1.480 |
Why?
|
| Neuroglia | 52 | 1992 | 925 | 0.970 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2024 | 3123 | 0.940 |
Why?
|
| Glial Fibrillary Acidic Protein | 51 | 1992 | 524 | 0.930 |
Why?
|
| Spinal Cord | 39 | 1992 | 1807 | 0.920 |
Why?
|
| Urinary Bladder Neoplasms | 9 | 2023 | 2229 | 0.860 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 2 | 2021 | 181 | 0.840 |
Why?
|
| Ureteral Obstruction | 2 | 2023 | 293 | 0.840 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4229 | 0.800 |
Why?
|
| Surgical Mesh | 3 | 2009 | 256 | 0.740 |
Why?
|
| Astrocytes | 38 | 1992 | 1266 | 0.740 |
Why?
|
| Neurofilament Proteins | 45 | 1995 | 318 | 0.730 |
Why?
|
| Cytoskeleton | 29 | 1990 | 1185 | 0.670 |
Why?
|
| Nerve Tissue Proteins | 63 | 1995 | 4465 | 0.650 |
Why?
|
| Brain Chemistry | 19 | 1993 | 981 | 0.580 |
Why?
|
| Fluorescent Antibody Technique | 79 | 1993 | 2505 | 0.580 |
Why?
|
| Office Visits | 1 | 2021 | 598 | 0.570 |
Why?
|
| Paclitaxel | 3 | 2023 | 1707 | 0.560 |
Why?
|
| Neurofibrils | 14 | 1984 | 76 | 0.560 |
Why?
|
| Intermediate Filaments | 14 | 1994 | 175 | 0.560 |
Why?
|
| Watchful Waiting | 4 | 2023 | 491 | 0.550 |
Why?
|
| Kidney | 9 | 2023 | 7167 | 0.540 |
Why?
|
| Robotics | 1 | 2023 | 892 | 0.540 |
Why?
|
| Hernia, Inguinal | 3 | 2009 | 202 | 0.530 |
Why?
|
| Cystectomy | 7 | 2023 | 682 | 0.490 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2023 | 798 | 0.450 |
Why?
|
| Kidney Pelvis | 2 | 2023 | 188 | 0.440 |
Why?
|
| Prostate-Specific Antigen | 12 | 2023 | 2458 | 0.430 |
Why?
|
| Axons | 21 | 1992 | 1681 | 0.430 |
Why?
|
| Ganglia, Spinal | 10 | 1992 | 517 | 0.420 |
Why?
|
| Rats, Inbred Strains | 40 | 1992 | 2191 | 0.400 |
Why?
|
| Wallerian Degeneration | 10 | 1993 | 70 | 0.400 |
Why?
|
| Nerve Regeneration | 11 | 1993 | 791 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 35342 | 0.370 |
Why?
|
| Male | 111 | 2024 | 349538 | 0.360 |
Why?
|
| Sciatic Nerve | 11 | 1993 | 609 | 0.360 |
Why?
|
| Rats | 103 | 1994 | 24265 | 0.360 |
Why?
|
| Retrospective Studies | 30 | 2024 | 77098 | 0.350 |
Why?
|
| Chyle | 1 | 2009 | 16 | 0.350 |
Why?
|
| Biopsy | 11 | 2023 | 6756 | 0.340 |
Why?
|
| Pheochromocytoma | 2 | 2011 | 337 | 0.330 |
Why?
|
| Laminin | 12 | 1993 | 418 | 0.330 |
Why?
|
| Adrenalectomy | 1 | 2011 | 342 | 0.330 |
Why?
|
| Nerve Degeneration | 11 | 1990 | 748 | 0.330 |
Why?
|
| Adenocarcinoma | 9 | 2021 | 6347 | 0.320 |
Why?
|
| Desmin | 7 | 1989 | 130 | 0.310 |
Why?
|
| Fistula | 1 | 2009 | 218 | 0.300 |
Why?
|
| Middle Aged | 61 | 2023 | 213127 | 0.300 |
Why?
|
| Optic Nerve | 14 | 1992 | 548 | 0.300 |
Why?
|
| Cerebellum | 20 | 1990 | 1490 | 0.290 |
Why?
|
| Humans | 136 | 2024 | 742088 | 0.280 |
Why?
|
| Molecular Weight | 28 | 1989 | 2255 | 0.280 |
Why?
|
| Nephrectomy | 5 | 2024 | 1049 | 0.280 |
Why?
|
| Peripheral Nerves | 7 | 2020 | 474 | 0.270 |
Why?
|
| Carrier Proteins | 12 | 1993 | 5019 | 0.270 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2011 | 740 | 0.270 |
Why?
|
| Hyaluronic Acid | 4 | 1993 | 489 | 0.270 |
Why?
|
| Epitopes | 16 | 1992 | 2569 | 0.260 |
Why?
|
| Muscles | 5 | 2023 | 1617 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 8 | 2021 | 3612 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2021 | 9185 | 0.260 |
Why?
|
| Testis | 2 | 2018 | 800 | 0.250 |
Why?
|
| Aged | 47 | 2023 | 162944 | 0.250 |
Why?
|
| Hematuria | 2 | 2011 | 235 | 0.250 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2018 | 933 | 0.230 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3070 | 0.230 |
Why?
|
| Neoplasm Staging | 10 | 2021 | 11001 | 0.230 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 1993 | 130 | 0.220 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2004 | 194 | 0.220 |
Why?
|
| Kidney Transplantation | 2 | 2009 | 4246 | 0.220 |
Why?
|
| Treatment Outcome | 19 | 2024 | 62966 | 0.210 |
Why?
|
| Neurons | 25 | 2008 | 9325 | 0.210 |
Why?
|
| Central Nervous System | 6 | 1987 | 1354 | 0.200 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2022 | 83 | 0.200 |
Why?
|
| Cattle | 30 | 1987 | 3923 | 0.200 |
Why?
|
| Vimentin | 15 | 1989 | 261 | 0.200 |
Why?
|
| Tuberculosis, Male Genital | 2 | 2018 | 6 | 0.200 |
Why?
|
| Kidney Diseases | 2 | 2010 | 2145 | 0.200 |
Why?
|
| Brain | 39 | 1995 | 26343 | 0.200 |
Why?
|
| Diagnostic Imaging | 4 | 2015 | 3507 | 0.190 |
Why?
|
| Muscle Proteins | 8 | 1982 | 1159 | 0.190 |
Why?
|
| Animals | 159 | 2015 | 168561 | 0.190 |
Why?
|
| Urinary Bladder | 4 | 2023 | 1171 | 0.190 |
Why?
|
| Immune Sera | 15 | 1984 | 641 | 0.190 |
Why?
|
| Urologic Surgical Procedures | 1 | 2023 | 301 | 0.190 |
Why?
|
| Neurons, Afferent | 6 | 1994 | 508 | 0.180 |
Why?
|
| Peritoneum | 1 | 2021 | 226 | 0.180 |
Why?
|
| Kidney Calculi | 1 | 2004 | 465 | 0.180 |
Why?
|
| Perineum | 1 | 2021 | 211 | 0.180 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2019 | 40 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 23 | 1992 | 9274 | 0.180 |
Why?
|
| Brachytherapy | 2 | 2022 | 1246 | 0.180 |
Why?
|
| Retina | 10 | 1991 | 2611 | 0.170 |
Why?
|
| Nerve Tissue | 3 | 1991 | 79 | 0.170 |
Why?
|
| Motor Neurons | 8 | 1994 | 851 | 0.170 |
Why?
|
| Spermatocele | 1 | 2018 | 9 | 0.170 |
Why?
|
| Autonomic Nervous System | 3 | 1994 | 671 | 0.170 |
Why?
|
| Kallikreins | 1 | 2020 | 258 | 0.170 |
Why?
|
| Urethra | 4 | 2022 | 408 | 0.160 |
Why?
|
| Prognosis | 12 | 2021 | 29010 | 0.160 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 505 | 0.160 |
Why?
|
| Varicocele | 1 | 2018 | 78 | 0.160 |
Why?
|
| Orchitis | 1 | 2018 | 35 | 0.160 |
Why?
|
| Epididymitis | 1 | 2018 | 37 | 0.160 |
Why?
|
| Antibody Specificity | 5 | 1987 | 1094 | 0.160 |
Why?
|
| Receptors, Androgen | 4 | 2018 | 1057 | 0.160 |
Why?
|
| Immunoenzyme Techniques | 15 | 1990 | 1799 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 19 | 1987 | 1801 | 0.150 |
Why?
|
| Diagnosis, Differential | 9 | 2022 | 12958 | 0.150 |
Why?
|
| Cisplatin | 1 | 2023 | 1637 | 0.150 |
Why?
|
| Incidental Findings | 2 | 2019 | 688 | 0.150 |
Why?
|
| Oxides | 2 | 2009 | 405 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2021 | 6534 | 0.140 |
Why?
|
| Goldfish | 3 | 1992 | 65 | 0.140 |
Why?
|
| Androstenes | 1 | 2018 | 169 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2008 | 2235 | 0.140 |
Why?
|
| Nerve Fibers | 8 | 1994 | 688 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1385 | 0.140 |
Why?
|
| Histocytochemistry | 16 | 1987 | 718 | 0.140 |
Why?
|
| Extracellular Matrix | 3 | 1993 | 1740 | 0.130 |
Why?
|
| Kuru | 2 | 1985 | 4 | 0.130 |
Why?
|
| Penile Diseases | 1 | 1996 | 46 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2021 | 1382 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 681 | 0.130 |
Why?
|
| Adult | 27 | 2023 | 213712 | 0.130 |
Why?
|
| Ureter | 2 | 2004 | 374 | 0.130 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 119 | 0.130 |
Why?
|
| Chickens | 11 | 1987 | 865 | 0.130 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 768 | 0.130 |
Why?
|
| Immunohistochemistry | 21 | 2022 | 11363 | 0.130 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 2 | 1985 | 89 | 0.120 |
Why?
|
| Lampreys | 2 | 1992 | 31 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15244 | 0.120 |
Why?
|
| Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.120 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39004 | 0.120 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2014 | 35 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 192 | 0.120 |
Why?
|
| Animals, Newborn | 9 | 1993 | 2723 | 0.120 |
Why?
|
| Myelin Sheath | 3 | 1992 | 652 | 0.120 |
Why?
|
| Dendrites | 4 | 1986 | 485 | 0.120 |
Why?
|
| Time Factors | 19 | 2020 | 40054 | 0.120 |
Why?
|
| Gliosis | 7 | 1991 | 243 | 0.110 |
Why?
|
| Urinary Diversion | 1 | 2014 | 137 | 0.110 |
Why?
|
| Ultrasonography | 4 | 2018 | 5978 | 0.110 |
Why?
|
| Lizards | 2 | 1990 | 55 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 953 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1417 | 0.110 |
Why?
|
| Afferent Pathways | 2 | 1991 | 302 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.110 |
Why?
|
| Immunodiffusion | 12 | 1980 | 163 | 0.110 |
Why?
|
| Survival Rate | 6 | 2019 | 12773 | 0.110 |
Why?
|
| Acrylamides | 2 | 1991 | 252 | 0.110 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 654 | 0.100 |
Why?
|
| Purkinje Cells | 5 | 1987 | 223 | 0.100 |
Why?
|
| Digestive System | 2 | 1991 | 251 | 0.100 |
Why?
|
| Iris | 4 | 1985 | 239 | 0.100 |
Why?
|
| Cystoscopy | 2 | 2009 | 134 | 0.100 |
Why?
|
| Spiral Ganglion | 3 | 1994 | 169 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2023 | 40450 | 0.100 |
Why?
|
| Wnt Proteins | 1 | 2015 | 721 | 0.100 |
Why?
|
| Hippocampus | 7 | 1990 | 3661 | 0.100 |
Why?
|
| Urethral Neoplasms | 1 | 2011 | 40 | 0.100 |
Why?
|
| Radiation Injuries | 2 | 2016 | 1178 | 0.100 |
Why?
|
| Disease-Free Survival | 6 | 2020 | 6891 | 0.100 |
Why?
|
| Aluminum | 3 | 1982 | 152 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2021 | 23320 | 0.090 |
Why?
|
| Lymphangiectasis | 1 | 2010 | 17 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2010 | 34 | 0.090 |
Why?
|
| Rabbits | 17 | 1990 | 4886 | 0.090 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3564 | 0.090 |
Why?
|
| Retroperitoneal Space | 1 | 2011 | 172 | 0.090 |
Why?
|
| Phosphorylation | 12 | 1995 | 8436 | 0.090 |
Why?
|
| Microscopy, Electron | 12 | 1993 | 2645 | 0.090 |
Why?
|
| Carcinoma | 2 | 2017 | 2374 | 0.090 |
Why?
|
| Iron | 2 | 2009 | 1773 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 2016 | 1167 | 0.090 |
Why?
|
| Lymphatic Metastasis | 4 | 2011 | 2906 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 1994 | 1617 | 0.090 |
Why?
|
| Prospective Studies | 7 | 2024 | 53187 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11472 | 0.090 |
Why?
|
| Polycythemia | 1 | 2010 | 126 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 849 | 0.090 |
Why?
|
| Diaphragm | 1 | 1991 | 347 | 0.080 |
Why?
|
| Spinal Nerve Roots | 1 | 1989 | 124 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1990 | 346 | 0.080 |
Why?
|
| Disease Progression | 3 | 2023 | 13256 | 0.080 |
Why?
|
| Fishes | 4 | 1986 | 569 | 0.080 |
Why?
|
| Androgen Antagonists | 2 | 2015 | 1350 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2566 | 0.080 |
Why?
|
| Embryo, Mammalian | 3 | 1992 | 1692 | 0.080 |
Why?
|
| Species Specificity | 9 | 1992 | 2479 | 0.080 |
Why?
|
| Antibodies | 12 | 1990 | 2459 | 0.080 |
Why?
|
| Schwann Cells | 3 | 1985 | 195 | 0.080 |
Why?
|
| Urography | 1 | 2009 | 313 | 0.080 |
Why?
|
| Cerebral Cortex | 11 | 1988 | 5705 | 0.080 |
Why?
|
| Risk Factors | 12 | 2023 | 72145 | 0.080 |
Why?
|
| Aging | 7 | 1990 | 8626 | 0.080 |
Why?
|
| Paraproteinemias | 1 | 2010 | 247 | 0.080 |
Why?
|
| Time Management | 1 | 2007 | 50 | 0.080 |
Why?
|
| Lymphatic Diseases | 1 | 2009 | 324 | 0.080 |
Why?
|
| Cyanogen Bromide | 4 | 1984 | 73 | 0.080 |
Why?
|
| Female | 48 | 2023 | 379592 | 0.070 |
Why?
|
| Olfactory Nerve | 1 | 1987 | 22 | 0.070 |
Why?
|
| Peptides | 7 | 1982 | 4392 | 0.070 |
Why?
|
| Chick Embryo | 5 | 1992 | 981 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 1825 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2005 | 12695 | 0.070 |
Why?
|
| Aged, 80 and over | 12 | 2021 | 57683 | 0.070 |
Why?
|
| Immunochemistry | 8 | 1988 | 124 | 0.070 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 546 | 0.070 |
Why?
|
| Bucladesine | 2 | 1990 | 121 | 0.070 |
Why?
|
| Preoperative Care | 3 | 2015 | 2245 | 0.070 |
Why?
|
| Bronchi | 1 | 1991 | 840 | 0.070 |
Why?
|
| Trinucleotide Repeats | 2 | 1998 | 261 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2021 | 3769 | 0.070 |
Why?
|
| Fibronectins | 6 | 1992 | 723 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 2008 | 367 | 0.070 |
Why?
|
| Cells, Cultured | 24 | 1992 | 19223 | 0.070 |
Why?
|
| Scrapie | 1 | 1985 | 22 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2011 | 921 | 0.070 |
Why?
|
| Anemia | 1 | 2015 | 1499 | 0.070 |
Why?
|
| Raphe Nuclei | 2 | 1986 | 104 | 0.060 |
Why?
|
| Urinary Fistula | 1 | 2005 | 41 | 0.060 |
Why?
|
| Ileus | 1 | 2005 | 58 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1990 | 895 | 0.060 |
Why?
|
| Astrocytoma | 3 | 1989 | 789 | 0.060 |
Why?
|
| Cartilage | 1 | 1989 | 818 | 0.060 |
Why?
|
| Trachea | 1 | 1991 | 1075 | 0.060 |
Why?
|
| Flank Pain | 1 | 2004 | 43 | 0.060 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1986 | 150 | 0.060 |
Why?
|
| Locus Coeruleus | 2 | 1984 | 176 | 0.060 |
Why?
|
| Nervous System | 2 | 1986 | 553 | 0.060 |
Why?
|
| Mesencephalon | 1 | 1986 | 327 | 0.060 |
Why?
|
| Versicans | 2 | 1993 | 33 | 0.060 |
Why?
|
| Obesity | 2 | 2012 | 12705 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2005 | 520 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 1986 | 420 | 0.060 |
Why?
|
| Ganglia, Sympathetic | 3 | 1990 | 62 | 0.060 |
Why?
|
| Cell Aggregation | 4 | 1979 | 244 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2014 | 1884 | 0.060 |
Why?
|
| Rectum | 1 | 2008 | 903 | 0.060 |
Why?
|
| Neuroblastoma | 2 | 1984 | 1225 | 0.060 |
Why?
|
| Polylysine | 3 | 1992 | 133 | 0.060 |
Why?
|
| Triacetoneamine-N-Oxyl | 1 | 2022 | 5 | 0.060 |
Why?
|
| Cell Differentiation | 16 | 1990 | 11470 | 0.050 |
Why?
|
| Autoantibodies | 3 | 1986 | 2036 | 0.050 |
Why?
|
| Staining and Labeling | 4 | 1991 | 1099 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9410 | 0.050 |
Why?
|
| Tubulin | 6 | 1991 | 695 | 0.050 |
Why?
|
| Immunoelectrophoresis | 6 | 1977 | 110 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 1988 | 2440 | 0.050 |
Why?
|
| Dogs | 6 | 1990 | 3910 | 0.050 |
Why?
|
| Vinblastine | 3 | 1980 | 490 | 0.050 |
Why?
|
| Colchicine | 2 | 1980 | 242 | 0.050 |
Why?
|
| Tissue Distribution | 5 | 1990 | 2335 | 0.050 |
Why?
|
| Synapses | 2 | 1990 | 1724 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 15056 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3528 | 0.050 |
Why?
|
| Culture Techniques | 3 | 1989 | 554 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2005 | 459 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2021 | 139 | 0.050 |
Why?
|
| Age Factors | 6 | 2020 | 18355 | 0.050 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1984 | 305 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5163 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2007 | 813 | 0.050 |
Why?
|
| Edema | 2 | 2018 | 790 | 0.050 |
Why?
|
| Mitosis | 1 | 1986 | 1208 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2005 | 494 | 0.050 |
Why?
|
| Boston | 3 | 2019 | 9305 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2021 | 8621 | 0.050 |
Why?
|
| Myelin Proteins | 1 | 1981 | 215 | 0.050 |
Why?
|
| Neurotoxins | 2 | 1994 | 237 | 0.040 |
Why?
|
| Head-Down Tilt | 1 | 2019 | 64 | 0.040 |
Why?
|
| Nitriles | 2 | 2015 | 952 | 0.040 |
Why?
|
| Multiple Sclerosis | 6 | 1989 | 3076 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2183 | 0.040 |
Why?
|
| Capsaicin | 2 | 1991 | 229 | 0.040 |
Why?
|
| Salvage Therapy | 2 | 2021 | 1269 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2005 | 761 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1986 | 1504 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 564 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2924 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 2522 | 0.040 |
Why?
|
| Amyloid | 1 | 1984 | 795 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2005 | 1248 | 0.040 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 933 | 0.040 |
Why?
|
| Cytoplasm | 2 | 1994 | 1539 | 0.040 |
Why?
|
| Glioma | 7 | 1989 | 3388 | 0.040 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2019 | 122 | 0.040 |
Why?
|
| Chromatography, Affinity | 5 | 1984 | 549 | 0.040 |
Why?
|
| Alzheimer Disease | 3 | 1985 | 7988 | 0.040 |
Why?
|
| Anterior Chamber | 2 | 1989 | 195 | 0.040 |
Why?
|
| Polymorphism, Genetic | 3 | 1998 | 4328 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1983 | 518 | 0.040 |
Why?
|
| Wounds, Penetrating | 2 | 1990 | 307 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2024 | 1353 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2921 | 0.040 |
Why?
|
| Mice | 24 | 2015 | 81045 | 0.040 |
Why?
|
| HIV-1 | 1 | 1996 | 6934 | 0.040 |
Why?
|
| Contrast Media | 2 | 2009 | 5295 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1986 | 1983 | 0.040 |
Why?
|
| Testicular Diseases | 1 | 2018 | 71 | 0.040 |
Why?
|
| Dopamine | 2 | 1986 | 1589 | 0.040 |
Why?
|
| Brain Stem | 2 | 1981 | 844 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 1902 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2004 | 746 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3465 | 0.040 |
Why?
|
| Vincristine | 1 | 1980 | 1036 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 1952 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1992 | 1989 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 1985 | 4554 | 0.040 |
Why?
|
| Rats, Mutant Strains | 2 | 1989 | 70 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 2 | 2009 | 360 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 1058 | 0.040 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 1997 | 62 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2019 | 322 | 0.040 |
Why?
|
| Cross Reactions | 6 | 1980 | 841 | 0.040 |
Why?
|
| Keratins | 4 | 1986 | 515 | 0.040 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1977 | 131 | 0.040 |
Why?
|
| Myosins | 1 | 1978 | 409 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20086 | 0.040 |
Why?
|
| Immunoblotting | 2 | 1991 | 1683 | 0.040 |
Why?
|
| Magnetite Nanoparticles | 2 | 2009 | 322 | 0.040 |
Why?
|
| Dextrans | 2 | 2009 | 592 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1866 | 0.040 |
Why?
|
| Dogfish | 2 | 1986 | 11 | 0.040 |
Why?
|
| Organ of Corti | 2 | 1994 | 84 | 0.040 |
Why?
|
| Trout | 2 | 1986 | 18 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 3 | 1985 | 135 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1203 | 0.030 |
Why?
|
| Propensity Score | 1 | 2023 | 1771 | 0.030 |
Why?
|
| Organ Culture Techniques | 2 | 1993 | 808 | 0.030 |
Why?
|
| Serotonin | 1 | 1981 | 1024 | 0.030 |
Why?
|
| Leukocyte Disorders | 1 | 2015 | 12 | 0.030 |
Why?
|
| Turtles | 3 | 1985 | 40 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2018 | 466 | 0.030 |
Why?
|
| Frontal Lobe | 2 | 1982 | 1407 | 0.030 |
Why?
|
| Eye Injuries | 1 | 1979 | 245 | 0.030 |
Why?
|
| Rats, Inbred F344 | 4 | 1986 | 862 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2615 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3391 | 0.030 |
Why?
|
| Proteins | 2 | 1981 | 6096 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2021 | 2633 | 0.030 |
Why?
|
| Cyprinidae | 1 | 1974 | 38 | 0.030 |
Why?
|
| Evoked Potentials | 3 | 1990 | 1057 | 0.030 |
Why?
|
| Mycobacterium | 1 | 1996 | 249 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1994 | 8300 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2030 | 0.030 |
Why?
|
| Acrylamide | 2 | 1991 | 60 | 0.030 |
Why?
|
| Incidence | 4 | 2017 | 20928 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 1995 | 220 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2018 | 21719 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1981 | 4143 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 143 | 0.030 |
Why?
|
| Isoelectric Focusing | 3 | 1989 | 181 | 0.030 |
Why?
|
| Guinea Pigs | 8 | 1990 | 1386 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3266 | 0.030 |
Why?
|
| Cell Division | 4 | 1990 | 4564 | 0.030 |
Why?
|
| Brain Neoplasms | 5 | 1989 | 8829 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1985 | 184 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1981 | 2552 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 546 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 19862 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1986 | 363 | 0.030 |
Why?
|
| Recurrence | 1 | 2004 | 8333 | 0.030 |
Why?
|
| Stents | 1 | 2004 | 3276 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2017 | 749 | 0.030 |
Why?
|
| Rats, Nude | 2 | 1989 | 105 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1911 | 0.030 |
Why?
|
| Rana pipiens | 2 | 1985 | 65 | 0.030 |
Why?
|
| Cerebellar Cortex | 1 | 1973 | 107 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1213 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1653 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 2 | 1989 | 771 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 1986 | 3691 | 0.030 |
Why?
|
| Antigens, Surface | 2 | 1990 | 1663 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1583 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6452 | 0.020 |
Why?
|
| Amino Acid Sequence | 5 | 1995 | 13814 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 1990 | 179 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 670 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2842 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 62 | 0.020 |
Why?
|
| Cell Movement | 3 | 1991 | 5212 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 1973 | 257 | 0.020 |
Why?
|
| Axonal Transport | 2 | 1989 | 177 | 0.020 |
Why?
|
| Amino Acids | 5 | 1981 | 1727 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 907 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12344 | 0.020 |
Why?
|
| Neuropeptides | 2 | 1994 | 942 | 0.020 |
Why?
|
| Neurites | 1 | 1992 | 380 | 0.020 |
Why?
|
| Ribs | 1 | 2012 | 250 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1993 | 834 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1990 | 399 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 1990 | 352 | 0.020 |
Why?
|
| Urinary Retention | 1 | 1991 | 110 | 0.020 |
Why?
|
| S100 Proteins | 3 | 1985 | 259 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3444 | 0.020 |
Why?
|
| Parietal Lobe | 2 | 1986 | 837 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 1993 | 588 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3455 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2015 | 10248 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 2010 | 269 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3278 | 0.020 |
Why?
|
| Pineal Gland | 1 | 1990 | 165 | 0.020 |
Why?
|
| Ganglia | 2 | 1986 | 89 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 1986 | 5662 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1992 | 1402 | 0.020 |
Why?
|
| Hexanones | 1 | 1988 | 7 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2417 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1990 | 1770 | 0.020 |
Why?
|
| Dementia | 2 | 1982 | 2501 | 0.020 |
Why?
|
| Cochlea | 1 | 1994 | 828 | 0.020 |
Why?
|
| HEPES | 1 | 1987 | 10 | 0.020 |
Why?
|
| Fetus | 3 | 1994 | 1879 | 0.020 |
Why?
|
| Sheep | 2 | 1985 | 1437 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 2027 | 0.020 |
Why?
|
| Clone Cells | 2 | 1984 | 1692 | 0.020 |
Why?
|
| Trypsin | 2 | 1986 | 509 | 0.020 |
Why?
|
| Skull | 1 | 2012 | 810 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
| Choristoma | 1 | 1989 | 213 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14720 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2015 | 2614 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1989 | 313 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2024 | 23387 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1986 | 59 | 0.020 |
Why?
|
| Ketones | 1 | 1988 | 189 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1987 | 158 | 0.020 |
Why?
|
| Quinolinic Acids | 1 | 1986 | 16 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1987 | 135 | 0.020 |
Why?
|
| Trigeminal Nerve | 2 | 1985 | 249 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2253 | 0.020 |
Why?
|
| Eye | 1 | 1991 | 728 | 0.020 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 1986 | 6 | 0.020 |
Why?
|
| Peptide Fragments | 4 | 1984 | 5095 | 0.020 |
Why?
|
| Cell Adhesion | 4 | 1989 | 3139 | 0.020 |
Why?
|
| Survivors | 1 | 2017 | 2286 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1974 | 930 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1990 | 7873 | 0.020 |
Why?
|
| Bufonidae | 1 | 1985 | 11 | 0.020 |
Why?
|
| Electrophoresis, Disc | 2 | 1977 | 70 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 548 | 0.020 |
Why?
|
| Oligodendroglia | 3 | 1981 | 514 | 0.020 |
Why?
|
| Azo Compounds | 1 | 1986 | 113 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1989 | 624 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2008 | 244 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13655 | 0.020 |
Why?
|
| Pancreatic Polypeptide | 1 | 1985 | 34 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1985 | 80 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1974 | 1554 | 0.020 |
Why?
|
| Gestational Age | 4 | 1989 | 3490 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 700 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7716 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 1985 | 229 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 357 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 790 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8425 | 0.020 |
Why?
|
| tau Proteins | 1 | 1994 | 1860 | 0.020 |
Why?
|
| Trigeminal Ganglion | 1 | 1985 | 186 | 0.020 |
Why?
|
| Pyridines | 2 | 1986 | 2818 | 0.020 |
Why?
|
| Congo Red | 1 | 1984 | 47 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1984 | 112 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1993 | 2867 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1984 | 199 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1989 | 2382 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1986 | 430 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1986 | 962 | 0.010 |
Why?
|
| Swine | 3 | 1995 | 5934 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2008 | 8297 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2014 | 2616 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1987 | 730 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9846 | 0.010 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 1983 | 10 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1984 | 682 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1990 | 1262 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1985 | 388 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12242 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4553 | 0.010 |
Why?
|
| Neutrophils | 1 | 2015 | 3711 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1984 | 235 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1982 | 49 | 0.010 |
Why?
|
| Carbonic Anhydrases | 1 | 1983 | 115 | 0.010 |
Why?
|
| Glycoproteins | 2 | 1983 | 2260 | 0.010 |
Why?
|
| Ependymoma | 2 | 1983 | 333 | 0.010 |
Why?
|
| Tryptophan | 1 | 1984 | 478 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1986 | 686 | 0.010 |
Why?
|
| Anencephaly | 1 | 1981 | 20 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 517 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1984 | 342 | 0.010 |
Why?
|
| Epidermis | 1 | 1985 | 527 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1986 | 13019 | 0.010 |
Why?
|
| Ileum | 1 | 1984 | 565 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1986 | 843 | 0.010 |
Why?
|
| Pons | 1 | 1982 | 245 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 1679 | 0.010 |
Why?
|
| Hair Cells, Auditory | 2 | 1994 | 361 | 0.010 |
Why?
|
| Mesoderm | 1 | 1984 | 686 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1983 | 309 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 774 | 0.010 |
Why?
|
| Arteries | 1 | 1986 | 1118 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1986 | 960 | 0.010 |
Why?
|
| Nanostructures | 1 | 2005 | 550 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1986 | 1074 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1986 | 670 | 0.010 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1980 | 23 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 484 | 0.010 |
Why?
|
| Epithelium | 1 | 1985 | 1680 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1986 | 2699 | 0.010 |
Why?
|
| Chordoma | 1 | 1983 | 359 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1983 | 334 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1179 | 0.010 |
Why?
|
| Antigens | 2 | 1977 | 1462 | 0.010 |
Why?
|
| Mass Screening | 1 | 2015 | 5238 | 0.010 |
Why?
|
| Cysteine | 1 | 1984 | 873 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1509 | 0.010 |
Why?
|
| Spleen | 1 | 1986 | 2359 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1981 | 366 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1986 | 1243 | 0.010 |
Why?
|
| Wakefulness | 1 | 1986 | 1243 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10372 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7010 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16665 | 0.010 |
Why?
|
| Medulla Oblongata | 2 | 1978 | 243 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1983 | 1725 | 0.010 |
Why?
|
| Graft Survival | 1 | 1989 | 3733 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 985 | 0.010 |
Why?
|
| Aorta | 1 | 1986 | 2057 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9941 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 1967 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1987 | 6382 | 0.010 |
Why?
|
| Optic Nerve Injuries | 1 | 1979 | 151 | 0.010 |
Why?
|
| Cell Line | 3 | 1980 | 15994 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2001 | 656 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13403 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1188 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1985 | 4013 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1998 | 242 | 0.010 |
Why?
|
| Pregnancy | 4 | 1992 | 29087 | 0.010 |
Why?
|
| Neuropeptide Y | 2 | 1990 | 200 | 0.010 |
Why?
|
| Piperazines | 1 | 1987 | 2488 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 188 | 0.010 |
Why?
|
| United States | 2 | 2016 | 69693 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3760 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4839 | 0.010 |
Why?
|
| Denervation | 2 | 1987 | 278 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1975 | 87 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 1990 | 305 | 0.010 |
Why?
|
| Maturation-Promoting Factor | 1 | 1995 | 26 | 0.010 |
Why?
|
| Dansyl Compounds | 1 | 1974 | 20 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1986 | 2971 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 2123 | 0.010 |
Why?
|
| 4-Butyrolactone | 1 | 1995 | 63 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 799 | 0.010 |
Why?
|
| Densitometry | 1 | 1974 | 156 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 252 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1995 | 112 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1981 | 1232 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1994 | 116 | 0.010 |
Why?
|
| Colorimetry | 1 | 1974 | 147 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1984 | 5454 | 0.010 |
Why?
|
| Phosphates | 1 | 1978 | 786 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 668 | 0.010 |
Why?
|
| Neurons, Efferent | 1 | 1994 | 82 | 0.010 |
Why?
|
| Seizures | 1 | 1987 | 2851 | 0.010 |
Why?
|
| Anura | 1 | 1973 | 85 | 0.010 |
Why?
|
| Goats | 1 | 1974 | 172 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 206 | 0.010 |
Why?
|
| Polyribosomes | 2 | 1984 | 110 | 0.010 |
Why?
|
| Phalloidine | 1 | 1993 | 21 | 0.010 |
Why?
|
| Microsomes | 2 | 1984 | 257 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2099 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1986 | 2407 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1976 | 1456 | 0.010 |
Why?
|
| Substantia Nigra | 2 | 1987 | 353 | 0.010 |
Why?
|
| Cats | 2 | 1985 | 998 | 0.010 |
Why?
|
| Mutation | 2 | 1974 | 29717 | 0.010 |
Why?
|
| Urea | 1 | 1974 | 449 | 0.010 |
Why?
|
| Cyclins | 1 | 1995 | 601 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 1777 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1983 | 1421 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2001 | 2205 | 0.010 |
Why?
|
| Actins | 1 | 1979 | 2120 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5062 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2001 | 1638 | 0.010 |
Why?
|
| Autopsy | 1 | 1974 | 1006 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6669 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1802 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 6259 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1985 | 2003 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1997 | 3587 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1990 | 141 | 0.010 |
Why?
|
| Androgens | 1 | 1997 | 1271 | 0.010 |
Why?
|
| Polysaccharide-Lyases | 1 | 1989 | 48 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 707 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 279 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18112 | 0.010 |
Why?
|
| Microtubules | 1 | 1995 | 1090 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1990 | 375 | 0.010 |
Why?
|
| Corpus Striatum | 2 | 1986 | 1220 | 0.000 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1990 | 265 | 0.000 |
Why?
|
| Length of Stay | 1 | 2001 | 6294 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1086 | 0.000 |
Why?
|
| Heparitin Sulfate | 1 | 1989 | 225 | 0.000 |
Why?
|
| Kinetics | 2 | 1989 | 6474 | 0.000 |
Why?
|
| Viscera | 1 | 1988 | 139 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6171 | 0.000 |
Why?
|
| Nomifensine | 1 | 1986 | 15 | 0.000 |
Why?
|
| Cytarabine | 1 | 1989 | 684 | 0.000 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1986 | 96 | 0.000 |
Why?
|
| Quinolinic Acid | 1 | 1986 | 68 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1986 | 169 | 0.000 |
Why?
|
| Testosterone | 1 | 1997 | 2401 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 218 | 0.000 |
Why?
|
| Alleles | 1 | 1997 | 6931 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1987 | 253 | 0.000 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1985 | 75 | 0.000 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1985 | 16 | 0.000 |
Why?
|
| Microinjections | 1 | 1986 | 326 | 0.000 |
Why?
|
| Biogenic Amines | 1 | 1984 | 50 | 0.000 |
Why?
|
| Myenteric Plexus | 1 | 1984 | 39 | 0.000 |
Why?
|
| Collagen | 1 | 1993 | 2684 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1984 | 240 | 0.000 |
Why?
|
| Paraffin | 1 | 1983 | 35 | 0.000 |
Why?
|
| Adrenal Medulla | 1 | 1983 | 58 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3800 | 0.000 |
Why?
|
| Desmosomes | 1 | 1983 | 73 | 0.000 |
Why?
|
| Monensin | 1 | 1983 | 29 | 0.000 |
Why?
|
| Mesentery | 1 | 1984 | 205 | 0.000 |
Why?
|
| Ciliary Body | 1 | 1984 | 172 | 0.000 |
Why?
|
| Cell Count | 1 | 1987 | 1831 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 3 | 1989 | 21821 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 12946 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1985 | 576 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1982 | 344 | 0.000 |
Why?
|
| Choroid | 1 | 1984 | 317 | 0.000 |
Why?
|
| Esophagus | 1 | 1988 | 1017 | 0.000 |
Why?
|
| Intestine, Large | 1 | 1981 | 71 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 1915 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1982 | 290 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1983 | 410 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1827 | 0.000 |
Why?
|
| Models, Neurological | 1 | 1990 | 1771 | 0.000 |
Why?
|
| Culture Media | 1 | 1983 | 902 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1985 | 1154 | 0.000 |
Why?
|
| Cell Communication | 1 | 1988 | 1619 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 774 | 0.000 |
Why?
|
| Thalamus | 1 | 1987 | 1023 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1984 | 1309 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 611 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 918 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1986 | 1124 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 1063 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15194 | 0.000 |
Why?
|
| Biopolymers | 1 | 1979 | 189 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1985 | 1811 | 0.000 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1978 | 39 | 0.000 |
Why?
|
| Intestines | 1 | 1988 | 1923 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1979 | 683 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3862 | 0.000 |
Why?
|
| Solubility | 1 | 1979 | 1083 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1986 | 1882 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1990 | 2024 | 0.000 |
Why?
|
| Disulfides | 1 | 1979 | 457 | 0.000 |
Why?
|
| Cell Survival | 1 | 1987 | 5872 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1974 | 18006 | 0.000 |
Why?
|
| Medulloblastoma | 1 | 1980 | 681 | 0.000 |
Why?
|
| Temperature | 1 | 1979 | 2207 | 0.000 |
Why?
|
| Adolescent | 3 | 1984 | 85649 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 9387 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1984 | 12071 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1980 | 3456 | 0.000 |
Why?
|
| Macrophages | 1 | 1977 | 5655 | 0.000 |
Why?
|